Raphael Ijeokwu

Scope and Efficacy of Semaglutide in Metabolic Dysfunction-associated Steatohepatitis: A Critical Review of Recent Evidences

Raphael Ijeokwu, Tuoyo Stephen Fregene, Farzana Rahman, Sobner Aubourg, Venkateshwarlu Kamishetty, Tiffany Abbey, Cindy Onumajuru, Ediomo Ekabua, Nawazuddin Mohammed, Sorrentina Awala, Alfred Ochong Ikpe, Jyothsna Goranti, Claudiane Mouafo Madzoom, Chukwuma Alphonsus Chuma-Eze & Tagbo Onyemelukwe · Journal of Advances in Medicine and Medical Research · 2026

Metabolic dysfunction-associated steatohepatitis (MASH), formerly termed nonalcoholic steatohepatitis (NASH), is a progressive hepatic manifestation of systemic metabolic dysfunction and a growing cause of cirrhosis, hepatocellular carcinoma, and liver transplantation. Semaglutid...

Open access Research Article 10.9734/jammr/2026/v38i86177

The Role of Gut Microbiome in Autism Spectrum Disorder (ASD) and Emerging Treatment Strategies

Raphael Ijeokwu, Simran Goraya, Hassan Muhammed Ul Haq, Rufus Okocha, Roshan Goswami, Elijah Oluwasegun Ayoigbala Adetunji, Mohammed Nawazuddin, Oghenerukevwe Faith Ohwodo, Shazia Noreen Durrani, Ayesha Taqi, Ademilua Oluwatobi Iyanuoluwa, Andeebia Ayub Khan, Olasumbo Elizabeth Fagbenle, Ogochi Blessing Chukwuneke, Patrick Batti & Jovita Echere · Journal of Advances in Medicine and Medical Research · 2024

Autism spectrum disorder (ASD) is a neurodevelopmental disorder. It is distinguished by repetitive behaviors, trouble in social interaction, and difficulty in communication. Recent research has demonstrated a strong association between gut microbiota and ASD. The purpose of this...

Open access Research Article 10.9734/jammr/2024/v36i105593